Date  |
|
| Feb 1, 2021 |
9 Meters Biopharma, Inc. Announces Research & Development Day on Short Bowel Syndrome |
| Feb 3, 2021 |
9 Meters Biopharma, Inc. highlighted at upcoming Truist Securities' CEO Strategic Vision Conference Call Series |
| Feb 10, 2021 |
9 Meters Biopharma, Inc. to Present at the 23rd Annual BIO CEO & Investor Conference |
| Mar 1, 2021 |
9 Meters Biopharma, Inc. Appoints Michael Rice to Board of Directors |
| Mar 9, 2021 |
9 Meters Biopharma, Inc. Announces Chief Medical Officer's Presentation at NIH's Accelerating Progress in Celiac Disease Workshop |
| Mar 10, 2021 |
9 Meters Biopharma, Inc. to Participate in the following Virtual March Investor Conferences |
| Mar 15, 2021 |
9 Meters Biopharma Hosting Key Opinion Leader Webinar on Short Bowel Syndrome and NM-002 Program Update |
| Mar 22, 2021 |
9 Meters Biopharma Provides Business Update and Reports Financial Results for the Fourth Quarter and Full Year 2020 |
| Mar 30, 2021 |
9 Meters Biopharma Announces Proposed Public Offering of Common Stock |
| Mar 30, 2021 |
9 Meters Biopharma Prices Public Offering of Common Stock |